Intra-voxel heterogeneity influences the dose prescription for dose-painting with radiotherapy: a modelling study 
Introduction
Radiotherapy treatment planning and delivery have been concerned with providing dose distributions across treatment volumes that are as uniform or 'flat' as possible. This is done with the full realization that heterogeneities in clonogen (cancer stem cell) density, proliferation, radiosensitivity and other biological variables result in non-uniform responses to such doses. A much more effective use of dose would be to create uniform responses across the tumour with respect to clonogenic survival. Imaging techniques that provide spatial information associated with biological and functional properties of tumour tissue inspired the development of 'dose-painting' or 'dose-painting-by-numbers' in which various different doses are prescribed to tumour regions based on some expectation of radiosensitivity in that region (Ling et al 2000 , Bentzen 2008 , Padhani et al 2007 , Tanderup et al 2006 , Rajendran et al 2006 , Schwartz et al 2005 , Stewart and Li 2007 , Gregoire et al 2007 , Olsen and Thwaites 2007 , Vanderstraeten et al 2006 , Tome and Fowler 2000 , Popple et al 2002 . Furthermore, several groups have demonstrated the technical feasibility of integrating image information in dose optimization and of delivering the corresponding heterogeneous dose distributions (Alber et al 2003 , Chao et al 2001 , Das et al 2004 , Yang and Xing 2005 , Thorwarth et al 2007 , Malinen et al 2006 , Xing et al 2002 , Sovik et al 2007b , Grosu et al 2007 . A variant of dose-painting-by-numbers is 'dose redistribution', where the dose is redistributed according to spatial differences in radiosensitivity without increasing the total tumour dose. This can lead to large therapeutic gains without increasing normal tissue toxicity (Sovik et al 2007a) .
The greatest interest in dose redistribution has been for addressing radioresistance associated with tumour hypoxia. At least three reasons make hypoxia an attractive target. First, hypoxia is a common feature of solid tumours that has been demonstrated to limit the efficacy of radiotherapy (Gray et al 1953 , Mottram 1936 , Seigneuric et al 2007 (Nordsmark et al 2005) . Second, several imaging methodologies can be used to image hypoxia including PET (Thorwarth et al 2005) , oxygen MRI (Malinen et al 2006) and dynamic susceptibility contrast enhanced MRI (Chen et al 2007) . Third, oxygenation patterns in tumours are highly heterogeneous and thus contribute to very non-uniform responses across the tumour. This spatial heterogeneity substantially increases the theoretic gains of dose redistribution.
The resolution of PET (3-5 mm (Saleem et al 2006) ), SPECT (7-8 mm (Grosu et al 2005) ) and MR techniques (<1 mm (Malinen et al 2006) ) is crude compared to the scale on which large variations in imaging parameters can occur. For instance, fully oxic and anoxic regions are typically separated by less than 150 μm (Gray et al 1953) . Consequently it is likely that all imaging voxels, regardless of the average oxygen concentration within the voxel, contain cells at a wide range of oxygen levels. Due to the elevated radioresistance of hypoxic cells and the exponential relationship between survival and dose, an under dosage to even one small hypoxic region (for example, within a voxel with a comparatively high average oxygen concentration) might offset expected gains or lead to a worse overall response. However, to date approaches for dose redistribution have applied average values from imaging voxels to all cells within the voxel uniformly. Although non-invasive imaging of the tumour microenvironment at the cellular level is technically impossible, underlying cellular distributions of micro-environmental properties can be estimated using modelling approaches based on histology sections or imaging data as input (Pogue et al 2001 , Secomb et al 2004 .
The goal of the present study was to estimate the expected cellular heterogeneity in oxygen concentration within imaging voxels and assess its importance for dose optimization by dose redistribution algorithms. The cellular oxygen distributions were estimated, based on their average voxel oxygen concentration, by modelling oxygen consumption and transport on the micro-environmental scale. Then these distributions were used to estimate the response of voxels to radiation dose in terms of cell kill and accordingly to determine the optimal dose to each voxel (∼mm 3 or ∼cm 3 ). The expected gains in cell kill that can be obtained by such dose redistribution were compared with approaches that apply the mean voxel oxygen concentration to all cells within the voxel.
Methods
This study addresses exclusively the effect of oxygen heterogeneity within voxels on dose determination. Other effects that might be equally or more important than intra-voxel heterogeneity for optimal dose determination were outside the scope of this study and are subject of extensive research elsewhere. In this study, it was assumed that each tissue element corresponding to an imaging voxel (∼mm 3 or ∼cm 3 ) could receive a homogeneous dose of arbitrary magnitude independent of its environment. The feasibility of delivering these ideal dose distributions was outside the scope of this study. For estimation of tumour response, the oxygen distributions within voxels were assumed to be stable in time. Potential differences in cell density or proliferation across the tumour voxels were ignored.
Tumour oxygenation data
The algorithms developed here are designed to be applied to tumours in which measurements of oxygen have been made through voxel-based imaging. Datasets could be obtained, for instance, with PET or other imaging methodologies which report back regional oxygenation values. However, there are few such datasets that have been collected in a large series of patients to date, and there remains some degree of uncertainty over the relationship between available PET isotopes and oxygenation. For the purposes here, we chose to use a dataset consisting of direct oxygen measurements made from polarographic oxygen electrodes as a surrogate of what might be expected from a clinical-based imaging dataset. Like PET and other imaging modalities, each measurement made by the electrode represents an average value of the oxygen concentration within a given volume. We are fully aware that in practice it is not feasible to base dose redistribution on such datasets, but the important point was to have a representative dataset that reflected the heterogeneity of oxygen distributions within defined volumes across different patient tumours. The dataset consists of a series of oxygen partial pressure (pO 2 ) measurement from 69 head and neck tumours measured with the Eppendorf oxygen electrode (Eppendorf, Hamburg, Germany). The importance of oxygenation on tumour response has been previously demonstrated in this patient series (Nordsmark and Overgaard 2000) .
The pO 2 measurements of the Eppendorf datasets ranged between 0 and 90 mmHg and were divided into 'bins' with a width of 2.5 mmHg. The pO 2 values >27.5 mmHg were combined into a single bin because no significant differences in radiosensitivity are expected above this level (Wouters and Brown 1997) . The average oxygen concentration in each bin varied from 1.25 to 28.75 mmHg with steps of 2.5 mmHg. The relative frequency of each bin for a given tumour represents the percentage of tumour voxels expected at each oxygen concentration.
Cellular oxygen distributions
The (measured) average oxygen concentration for each bin was used to estimate an underlying theoretical cellular oxygen distribution inside the voxels. When the positions of and the pO 2 in the capillaries in a tissue segment are known, the oxygen concentration in the surrounding cells can be calculated (Dasu et al 2003 , Pogue et al 2001 , Dasu and Toma-Dasu 2008 . In this study we employed a Monte Carlo approach to simulate the positions of and the pO 2 values in the capillaries in a voxel, based only on its mean pO 2 , in order to obtain an estimate of its underlying cellular oxygen distribution. It was assumed that the cellular oxygen distribution in an imaging voxel (with a volume in the order of mm 3 or cm 3 ) could be estimated using a theoretical two-dimensional tissue element containing 100 × 100 cells of 10 × 10 μm 2 in correspondence to Kelly et al (Kelly and Brady 2006) , with capillaries placed orthogonally occupying an area of four squared cells. Assuming perpendicularity leads to an underestimation of oxygenation for a fixed number of capillaries (Kelly and Brady 2006) , but this is no issue in the current study since the pO 2 distribution and vascularization are fitted to the mean voxel pO 2 . The presented method can also be extended to 3D, but because our interest is with respect to the fraction of cells as a function of pO 2 inside the voxels and not to the 3D spatial oxygen distribution, it is expected that a 2D approximation suffices. These approximations are discussed further in section 4.
To derive a theoretical cellular pO 2 distribution based on the mean voxel pO 2 , an initial number of capillaries were placed at random on the tissue element and the corresponding spatial, cellular pO 2 distribution was calculated (see section 2.3). Then, capillaries were added or removed until the mean pO 2 of the distribution corresponded to the mean voxel pO 2 (figure 1). To reflect the chaotic vasculature of tumour tissue the capillaries were not placed at regular intervals but at random positions for each simulation, with the only restriction of a minimal inter-capillary distance of 20 μm (at least two cells in between capillaries). Such a low inter-capillary distance ensured formation of chaotic vasculatures. The pO 2 in each capillary is sampled from a Gaussian distribution with mean and standard deviation 35 mmHg and 7 mmHg, respectively, which approximates experimental findings (Wilson et al 2002) . Naturally, fitting a distribution based on its mean yields a large number of solutions. The variability of all possible cellular oxygen distributions was estimated by performing 100 simulations, yielding 100 different cellular oxygen distributions for each average voxel pO 2 . The fraction of cells in voxel i with oxygen level p j in the kth simulation is denoted by f ij k .
Oxygen equations
The cellular oxygen distribution corresponding to a given capillary configuration was calculated using a method proposed by Dasu et al (2003) . These authors stated that on the cellular scale convection of oxygen can be neglected and that the pO 2 can be considered as stationary and described by the partial differential equation:
with p being the pO 2 , D the diffusion coefficient, c max the maximum oxygen consumption rate and k the oxygen partial pressure value for which the consumption rate is equal to half-maximum. The left-hand side of this equation represents diffusion of oxygen and the right-hand side oxygen consumption. In correspondence to these authors D, c max and k are set to 2 × 10 −5 cm 2 s −1 , 15 mmHg s −1 and 2.5 mmHg, respectively. A finite differences approach implemented in Matlab 7.1 SP3 was used to solve the equations. The capillaries were considered as oxygen sources and at the border of the calculation domain periodic boundary conditions were applied.
Tumour response
This section describes how the cellular oxygen distributions within voxels, f ij k , can be used to estimate cell survival in a voxel i, of which the mean pO 2 is known and that is irradiated with a homogeneous dose D i . The survival probability S of a cell as a function of its pO 2 and the dose D can, according to Wouters and Brown (1997) , be described using a modified version of the linear-quadratic (LQ) model:
with p being the cellular pO 2 and OERα and OERβ the oxygen enhancement ratios of α and β, respectively, given by
and
OERα m and OERβ m are the maximum values under aerobic conditions of OERα and OERβ, and K m is the pO 2 at which half-sensitization is achieved. K m is set to 3.28 mmHg and OERα m and OERβ m to 2.5 and 3.0, respectively (Wouters and Brown 1997) . These OERα m and OERβ m values were purely based on in vitro experiments. Therefore, the effect of the variations in these parameters was studied. α and β are the linear quadratic coefficients under aerobic conditions and α H and β H under hypoxic conditions. α H and β H are related by α and β by division by OERα m and (OERβ m ) 2 respectively. We used an α/β ratio of 10 Gy and a survival after 2 Gy irradiation under aerobic conditions of 0.37 (Sovik et al 2007a , Pekkola-Heino et al 1995 yielding α and β values of 0.41 Gy −1 and 0.041 Gy −2 , respectively. The survival fraction SF of the cells inside voxel i after one irradiation fraction with a uniform dose D i to voxel i is given by
with p i being the mean voxel pO 2 in voxel i, g ij the fraction of viable cells with oxygen level p j inside voxel i and D i the dose delivered to voxel i. This equation can easily be extended to include a voxel-specifc proliferation rate by adding the factor ln(2) T /T pi to the exponent with T being the total treatment time and T pi the potential cell doubling time in voxel i (Yang and Xing 2005) . But this was outside the scope of our study. The surviving fraction in voxel i after n radiation fractions SF n i is given by
In correspondence with Wouters and Brown (1997) , the surviving fraction was calculated by assuming full reoxygenation of the surviving cells between fractions, which yields the same overall voxel response to each fraction. The surviving fraction across the entire tumour after n fractions SF n T is the weighted summation of SF n i over all voxels:
with L being the total number of voxels.
Dose distribution optimization
Dose distributions were optimized twice for each tumour by varying the dose level to each tumour voxel. In the first approach, we assumed that voxels are homogeneous with respect to oxygen (homogeneous voxel model HomVM), i.e. each cell in the voxel is exposed to the mean oxygen concentration of the voxel itself. Thus,
For the second, we used an estimate of the cellular oxygen distribution within the voxel calculated as the average cellular distribution of the 100 different derived cellular oxygen distributions for that voxel (heterogeneous voxel model HeteVM) i.e.
The optimal dose level to each voxel was determined by solving equation (10) using a simulated annealing approach with a steepest descent algorithm to yield minimal tumour survival after 30 fractions of 2 Gy (SF 30 ):
The mean dose to the tumour was restricted to 2 Gy per fraction to avoid an increase in total dose compared to a uniform dose distribution of 2 Gy that was used as a reference. In this way, we could strictly compare expected tumour responses to a 'flat' 2 Gy dose with that of a redistributed equivalent dose. The dose per voxel was allowed to vary between 1 and 5 Gy. It is emphasized that this is not an optimization of the dose to each tumour cell, but of the dose to each voxel by using the cellular oxygen distribution to calculate the response of the voxel. We assumed that each voxel could receive an arbitrary, homogeneous dose independent of its surroundings.
The effectiveness of the dose distributions in terms of tumour cell kill was evaluated by comparing SF 30 values (calculated using equation (7)) and calculating the gain in cell kill, which was defined as the SF 30 of one dose distribution divided by the SF 30 of a second dose distribution. Since the actual cellular oxygen distributions for each voxel in each tumour are variable and unknown, the effectiveness of both derived dose distributions was assessed 1000 separate times within the 69 tumours using randomly chosen cellular oxygen distributions from the 100 distributions, f ij k , that were derived for each average voxel pO 2 . Thus each time
The quantities 'survival fraction' and 'gain in cell kill' are intuitive and easy to comprehend; however, a disadvantage is that they strongly depend on the total radiation dose. For instance, it is not straightforward to extrapolate the gain in cell kill at a radiation dose of 60 Gy to, for example, 70 Gy. A more objective measure to compare the effectiveness of two different dose distributions is the dose enhancement ratio (DER), defined here as the ratio in total dose (2 Gy/fraction) that is needed to obtain a certain survival fraction with one dose distribution compared to the other (figure 2). The DERs of the HeteVM (DER HeteVM ) and HomVM (DER HomVM ) dose distributions were calculated compared to a uniform dose distribution. The baseline for comparison was in both cases the SF 30 with the HeteVM dose distribution, i.e. the DER values were calculated for a survival fraction equal to the SF 30 corresponding to the HeteVM dose distribution.
Acute hypoxia
Changes in oxygen concentration in time, typical of acute hypoxia, are expected to reduce the potential gains of dose redistribution. We therefore assessed how such transient changes in oxygen would affect the theoretical gains achieved by the dose distributions optimized by the HomVM and HeteVM models. The effect of acute hypoxia was modelled by setting the mean pO 2 of a fraction of voxels, chosen at random before each irradiation fraction, to the lowest oxygen level (1.25 mmHg) and letting them reoxygenate to their original pO 2 before the next fraction. For this purpose, a tumour was modelled containing 1000 voxels distributed according to the voxel pO 2 distribution of one of the Eppendorf datasets. The simulations were repeated 100 times per acute hypoxia fraction and each time the DER HeteVM and the DER HomVM of the optimized dose distributions were calculated. The dose enhancement ratio (DER) is indicated and defined as the ratio in total dose needed to obtain the same surviving fraction with one dose distribution compared to another. The baseline for comparison is the survival that is obtained with the HeteVM dose distributions after a total fractionated dose of 60 Gy.
Results

Derivation of cellular oxygen distributions within voxels
The cellular oxygen distributions were derived separately 100 times per voxel. The averages of these 100 different distributions and standard deviations are shown in figure 3 . All voxels, regardless of the average pO 2 , contain a large range of cellular pO 2 values with severely hypoxic cells (pO 2 < 2.5 mmHg) being present in voxels with average pO 2 values up to 21.25 mmHg.
In the voxels with average pO 2 < 12.5 mmHg, the distributions are dominated by severely hypoxic cells. As the average voxel pO 2 increases, the cellular oxygen distributions approach a Gaussian shape with a mean equal to the average voxel pO 2 .
Cell survival within voxels
The surviving fraction of cells within the different voxels to 1 or 30 fractions of 2 Gy was calculated for each 100 times using the different derived cellular oxygen distributions (HeteVM) and simply assuming that all cells within the voxel were exposed to the average voxel pO 2 (HomVM) as was employed previously. As shown in figure 4 , when intra-voxel oxygen heterogeneity is taken into account, a much more radioresistant response is predicted than when all cells are assumed to have a homogeneous cellular pO 2 within the voxel. For voxels with pO 2 values higher than 25 mmHg both models resulted in identical surviving fractions, but as the average voxel pO 2 decreases the difference in cell kill, as predicted by the two models, increases up to ∼150 fold after 60 Gy at 3.75 mmHg. This was expected and derives from the nonlinear relationship among survival, dose and pO 2 . Thus, ignoring the cellular oxygen distributions results in an overestimation of cell kill and in an underestimation of the differences in cell kill across the different voxels.
Effect on dose determination
Optimal dose distributions were determined as described in section 2 using either the HeteVM or HomVM for 69 individual patient tumours for which oxygen measurements have been made (Nordsmark and Overgaard 2000) . During the dose optimization with the HeteVM, each voxel was represented by the average cellular distribution made from the 100 different derivations for each average voxel pO 2 (shown in figure 4 ). For the HomVM the cellular oxygen concentration was uniform and equal to the average pO 2 in each voxel. Since the actual cellular oxygen distributions within voxels are unknown and variable, we simulated the range of responses that might be expected in each of the 69 tumours if these resulting dose distributions were delivered and compared them to a standard 2 Gy uniform dose. This was carried out by applying the dose distributions to each tumour 1000 times, each time choosing randomly one of the 100 different derived cellular oxygen distributions for each voxel. The mean and standard deviation of SF 30 corresponding to the different dose distributions are shown in figure 5 for all the analysed tumours. For convenience the tumours are sorted according to the calculated mean SF 30 after a uniform dose distribution of 2 Gy in 30 fractions. The position on the x-axis is thus a measure of the expected radioresistance of the tumours with left and right tumours that are relatively sensitive and resistant, respectively. Our simulations indicate that dose redistribution with the HomVM could result in a median gain in cell kill for all tumours of 22 fold (range (1-862)) compared to a uniform dose distribution, whereas the HeteVM could yield larger gains with a median of 72 fold (range (1-6815) ). The bottom figure of figure 5 shows the average additional gain in cell kill of the dose distributions of the HeteVM compared to the HomVM. As follows from our simulations, the median of the additional gain is two fold (range (1-24) ). However, a large fraction of the tumours shows much larger gains of up to 24 folds. The HeteVM distributes more dose from the radiosensitive to the radioresistant voxels expressed by the larger dose decrease to radiosensitive voxels by the HeteVM compared to the HomVM; the median of the minimal dose was 1.55 Gy/fraction (range (1.17-2.0)) with the HeteVM compared to 1.65 Gy/fraction (range (1.29-1.97)) with the HomVM.
A more objective measure to compare the effectiveness of two dose distributions is the dose enhancement ratio (DER). On the left side in figure 6 the DER HeteVM is plotted for the 69 tumours. The median DER HeteVM is 1.30 (range (1.00-1.70)), meaning that our model indicates that 30% more dose is needed to obtain the same amount of cell kill with a uniform dose distribution as with the HeteVM dose distributions. Dose optimization with the HomVM leads to smaller DER values; the median of the ratio DER HeteVM /DER HomVM is 1.05 (range (1.0-1.15)) (figure 6 right). For a substantial number of the tumours (17%) the ratio is larger than 1.1. Thus dose distributions that are optimized with the HeteVM are better matched to spatial differences in oxygenation and are therefore more effective than those of the HomVM.
Influence of acute hypoxia and the maximum oxygen enhancement ratio
Changes in oxygenation over time are likely to detract from the efficacy of dose redistribution. Since more heterogeneous dose distributions are expected to be less robust to changes in spatial differences in radiosensitivity than uniform or less heterogeneous dose distributions, we estimated the consequences of acute hypoxia on the response for one of the tumours treated with the different dose distributions. This is shown in figure 7 where the DER HeteVM and the DER HomVM are plotted against the fraction of acute hypoxic voxels for tumour number 21. The presence of acute hypoxia changes at random the spatial differences in radiosensitivity across the tumour and therefore diminishes the effectiveness of the dose redistribution that was matched to some expectation of radiosensitivity that is disturbed by the acute hypoxia. The effectiveness of dose redistribution using either the HomVM or HeteVM diminishes with an increasing fraction of acute hypoxia. Because the dose distributions of the HeteVM are more heterogeneous than the dose distributions of the HomVM, this effect is larger for the former than for the latter, indicated by the reduced gain in dose effectiveness as more voxels experience acute hypoxia. As the fraction of acute hypoxic voxels increases the dose distributions of the HomVM become more effective than those of the HeteVM. The HeteVM and HoVM do worse than a flat dose for this particular tumour when more than three quarters of the voxels become acutely hypoxic. These patterns are characteristic for the other tumours that were analysed in this study although the steepness of the curves and points of intersection may vary.
The effect of the OERα m and OERβ m parameters on the presented DER values was investigated for tumour number 26. The OERβ m was varied from 1 to 10 while the ratio Figure 6 . The left figure shows the dose enhancement ratios (DERs) that are obtained with the dose distributions that were optimized with the HeteVM. The error bars indicate one standard deviation. The right figure shows the DER ratio corresponding to the dose distributions that are optimized with the HeteVM and with the HomVM. For all tumours the ratio is larger than 1, which indicates more dose is needed with the latter than with the former to achieve the same level of cell kill. OERα m /OERβ m was kept constant to 0.833. For smaller OERβ m values than used in this study both the DER HeteVM as the difference between DER HeteVM and DER HomVM decreased down to a DER of 1 for an OERβ m of 1, whereas for higher OERβ m both increased (figure 8). Figure 5 shows that regardless of which model is used for dose determination, the gains in cell kill that can be achieved with dose redistribution tend to decrease as tumours become more radioresistant (increased overall levels of hypoxia). This is demonstrated in figure 9 that shows the DER HeteVM as a function of the mean tumour pO 2 . The DER HeteVM increases with mean tumour pO 2 until 22 mmHg. For higher oxygen pressures smaller DER values are observed. This means that in terms of the DER, severely hypoxic tumours and fully aerobic tumours are expected to benefit less from dose redistribution than moderately hypoxic tumours. The somewhat paradoxical finding that less hypoxic tumours gain more from dose redistribution arises due to a reduction in oxygen heterogeneity within these tumours. Tumours with the highest level of heterogeneity, i.e. those containing voxels at both high-and low-pO 2 levels, gain most from dose redistribution and these tumours tend to be those that have an overall moderate hypoxic fraction.
Potential of dose redistribution varies per tumour
Discussion
For a large proportion of patients the dose needed to cure the tumour cannot be reached in current radiotherapy due to normal tissue complications (Verellen et al 2007) . These patients might benefit from an additional boost dose to the most radioresistant part of the tumour if these areas could be identified and boosted safely. An additional means to improve tumour response and to further increase dose to radioresistant tumour regions is to redistribute dose from radio-sensitive regions. A number of obstacles have slowed down clinical implementation of dose redistribution. It is difficult to establish a direct relationship between biological images and the desired dose (Bentzen 2005) . Furthermore, images acquired before the start of therapy may not be representative of the situation during treatment (Bosmans et al 2006 , van Baardwijk et al 2007 . Delivery of complex dose distributions to tumours is also difficult and requires increased precision in patient and tumour positioning, which is challenging because of the extra time needed to deliver a dose redistribution plan (Hall 2005) . Moreover it is not clear whether the spatial resolution of imaging techniques is sufficient to reflect the biological tumour heterogeneity (Tanderup et al 2006) . The aim of this study was to asses, in isolation, the effect of oxygen heterogeneity within imaging voxels on the best determination of dose redistribution algorithms. We ignored the potential effects of proliferation, cell density, physical restrictions of dose delivery and uncertainties in the calibration from image intensity to voxel pO 2 on the optimal choice of dose. These processes will certainly decrease the efficacy of dose redistribution, but to estimate exclusively the effect of oxygen heterogeneity in voxels, we chose to ignore them here.
We have shown that each tumour voxel is likely to contain cells at a large range of oxygen concentrations and that voxels with mean pO 2 values <12.5 mmHg are even dominated by severely hypoxic cells. The radiosensitivity of cells as a function of pO 2 is almost constant above 20 mmHg but decreases exponentially with decreasing pO 2 . Consequently all voxels that contain a substantial amount of cells with pO 2 < 20 mmHg are in reality more radioresistant than expected when they are assumed to be homogeneous. As a result ignoring intra-voxel oxygen heterogeneity leads to large overestimations in cell kill.
A second consequence of this heterogeneity, and more relevant to algorithms for determining the optimal way to redistribute dose, is that differences in radiosensitivity between different voxels are underestimated when average voxel concentrations are used. Dose redistribution (with a restrictive integral dose) only makes sense if one tumour region is more radioresistant than a second. The larger the difference the more effective dose redistribution can be. So when intra-voxel heterogeneity in oxygen is acknowledged for dose determination, more dose is redistributed from aerobic to hypoxic voxels. In our analysis of 69 tumours, use of cellular oxygen distributions in the algorithm yielded more effective dose distributions in terms of cell kill compared to a model that assumes that all cells within a voxel are exposed to the same pO 2 .
In this study a maximum cellular OERβ of 3 was employed (not to be confused with the tumour OER, which depends on the oxygenation of the tumour). This value was derived from in vitro studies, but in the in vivo situation it may be reduced in some hypoxic cells that are also deprived of nutrients. Therefore the effect of the OERβ on the DER was investigated. Because the OER reflects the difference in radiosensitivity between fully hypoxic and fully aerobic cells, it follows that higher OER values result in larger DER values. In addition the influence of intra-voxel heterogeneity increases and the difference between the HomVM and HeteVM becomes larger. The opposite is true for lower OER values than employed here.
Our simulations indicated that although the HeteVM are more effective than the HomVM dose distributions they are less robust to discrepancies between the real oxygenation status of the tumour and the one expected prior to dose determination, caused for instance by acute hypoxia or other changes in oxygenation. This is a consequence inherent to dose redistribution and holds for all disturbances of the expected spatial differences in radiosensitivity, whether they are caused by oxygen, proliferation, differences in cell density etc. Dose distributions that are better matched to the expectation of radiosensitivity in each voxel are more powerful if this expectation is realized but more sensitive to deviations, than dose distributions with a smaller range in dose. Ideally dose distributions should be determined based on differences in radiosensitivity and weighted by the probability that the expected radiosensitivity is realized. More uncertainty should lead to more homogeneous dose distributions and ultimately to a conventional uniform dose, whereas less uncertainty should lead to more heterogeneous dose distributions.
During the course of this analysis, we observed that the benefit from dose redistribution is strongly dependent on the spatial differences in oxygen concentration across a tumour and on the amount of aerobic tumour voxels. If the differences in oxygen are small there is no reason to redistribute dose (based on differences in oxygenation), but if they are large dose redistribution can yield large theoretic gains. The maximum dose increase to hypoxic regions is determined by the amount of aerobic voxels because a dose increase in one region must be compensated by a dose decrease in another region to maintain a certain restrictive mean dose. Correspondingly our simulations showed that moderately hypoxic tumours can benefit more from dose redistribution in terms of the DER (without administering a boost dose) than severely hypoxic tumours. This observation is interesting because at the same time the need for dose redistribution is smaller for moderately hypoxic tumours because they respond better to radiotherapy in the first place, whereas especially for hypoxic tumours strategies are needed to counteract the hypoxic radioresistance. It should be noted that this holds when the tumour dose is strictly redistributed and not necessary when it is increased compared to the uniform dose distribution (boosting).
It should be emphasized that the dose enhancement ratios or increase in cell kill that we have calculated to assess differences in the effectiveness of the dose distributions are not measures of the clinical benefit that might be expected. Instead, these values are aimed at assessing how much the effect of dose can be enhanced by redistribution. Advantages of the DER compared to more 'clinical' measures as tumour control probability (TCP) or SF 30 is that it describes the relative effect of a dose distribution compared to a reference dose distribution independent on the number of tumour cells, which is generally not known. Moreover it is dimensionless and therefore easy to interpret independent on the magnitude of the dose at which level it is computed. A disadvantage of DER is that it can be quite large and at the same time clinically irrelevant when tumour control is almost perfect anyway by the reference dose distribution. The choice to use dose redistribution clinically will ultimately depend on a number of other clinical and technical considerations. These include parameters that influence differences in radiosensitivity across the tumour and throughout the course of therapy. For example, the important influence of acute hypoxia, reoxygenation, radiosensitivity of acutely versus chronically hypoxic cells, clonogen density and other parameters was recently demonstrated by Sovik et al (2007a) . The models proposed here are intended exclusively to estimate the effect of voxel heterogeneity for dose determination. For this purpose the DER is believed to be a suitable measure.
This study has a few limitations that need to be addressed. Because we focused solely on the effect of intra-voxel heterogeneity on dose determination, and ignored a number of other factors that will influence the clinical benefit, the presented DER values should be interpreted with caution. These are most informative to evaluate the relative performance of different dose prescription algorithms. We also assumed that changes in oxygenation over time, apart from reoxygenation, did not occur. If there are changes however, they might affect the efficacy of dose redistribution (Lin et al 2008) . Third the cellular oxygen distribution within a voxel was simulated on a 2D tissue element with orthogonal capillaries. The positions of the capillaries were restricted only by the minimal inter-capillary distance of 20 μm. Compared to the capillary diameter, the current study applied a relatively low value yielding minimal regularization of tumour vasculature. Simulations using a more realistic 3D geometry may yield different oxygen distributions, but the effect is expected to be moderate compared to the differences in cellular oxygen distributions that might occur in reality between different tumour voxels with the same mean pO 2 . We emphasize that the end points of our simulations are distributions of the percentage of cells inside a voxel as a function of pO 2 and not the spatial oxygen distributions. By calculating the former from the latter (whether it is 2D or 3D) naturally information is lost. This means that fundamental differences in the oxygen distribution between the 2D and 3D simulations diminish in this step. In figure 5 we assessed the variability of the response of voxels on the dose by using each time for each voxel at random one of the 100 cellular oxygen distributions that were derived for that oxygen level to calculate its response. It is unlikely that the cellular distribution determined by a 3D model would produce a voxel oxygen distribution that would respond outside of this range.
The approach that we describe makes optimal use of the dose delivered to the tumour by distributing it in such a way as to minimize the heterogeneity in response that arises from expected cellular distributions of oxygenation.
Conclusion
We performed a modelling study to investigate the importance of intra-voxel heterogeneity for tumour dose redistribution. Our simulations indicated that failure to incorporate intra-voxel heterogeneity in oxygenation leads to large overestimations of cell kill by cell survival models; if intra-voxel heterogeneity is included in dose optimization plans, the dose can be redistributed more efficiently to yield more effective tumour cell kill; the resulting dose distributions are better matched to the expected tumour oxygen distribution during therapy but therefore more sensitive to deviations from it. Finally, based on our model it can be expected that moderately hypoxic tumours benefit more from dose redistribution than severely hypoxic tumours.
